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balance of the mechanisms regulating cell division,
differentiation and death. We have investigated the
signalling mechanisms involved in regulation of the balance
between cell proliferation and apoptotic cell death in the
otic vesicle. The sphingomyelin pathway signals apoptosis
for nerve growth factor upon binding to p75 receptors. It
is initiated by sphingomyelin hydrolysis to generate the
second messenger ceramide. In the present study, we show
that nerve growth factor stimulates sphingomyelin
hydrolysis and the concomitant ceramide release in
organotypic cultures of otic vesicles. Both nerve growth
factor and ceramide induce apoptotic responses to a
different extent. Ceramide-induced apoptosis was
suppressed by insulin-like growth factor-I which is a strong
promoter of cell growth and morphogenesis for the
developing inner ear. In contrast, ceramide-1-phosphate
protected the explants from apoptosis induced by serum
withdrawal but did not antagonise ceramide-induced cell
death. This study suggests that sphingomyelin-derived
second messengers might be key modulators of
programmed cell death during development.
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SUMMARYINTRODUCTION
Programmed cell death is a physiological process during
development (Raff et al., 1993; Jacobson et al., 1997). In the
nervous system it is essential at early developmental stages for
tissue morphogenesis and neurogenesis, before innervation
(Glücksmann, 1951; Saunders, 1966). Apoptosis has been
reported to be modulated by cytokines including insulin-like
growth factor-I (IGF-I) and nerve growth factor (NGF). IGF-I
is a potent suppressor of cell death in a variety of cell types but
little is known about its role during early embryonic
development (Harrington et al., 1994; O’Connor et al., 1997).
NGF has been shown to both trigger apoptosis and promote
cell survival depending on the cell type and stage of
development (Xia et al., 1995; Nobes and Tolkovsky, 1995;
Davies, 1997). Distinct actions of NGF can be achieved by
selective binding to either trkA or p75 receptors (Frade et al.,
1996). 
The signalling pathways mastering apoptosis during early
organogenesis are poorly characterised. Ceramide (Cer)
generation by the action of sphingomyelinase has been
proposed to be a potent inductor of programmed cell death.
This pathway is turned on by a number of effectors including
CD95 (Apo-1/Fas), tumor necrosis factor, ionizing radiation or
chemotherapeutic agents (reviewed by Hannun, 1996), and has
been extensively studied in the immune system (Cifone et al.,
1994; Gill et al., 1994). Sphingomyelin/Cer turnover is also
activated by NGF in primary cultures of postnatal
oligodendrocytes (Casaccia-Bonnefil et al., 1996). Cer actions
are exerted through the activation of specific kinase and
phosphatase activities (Joseph et al., 1993; Dobrowsky et al.,
1994). Other downstream targets for ceramides are
phospholipase D, protein kinase C- z , Ras, Vav, Raf and the
transcription factor NFk B (for reviews see Spiegel and Merril,
1996; Hannun, 1996). Cer can be converted to ceramide-1-
phosphate (Cer-1-P) by the action of a calcium-dependent
kinase (Dressler and Kolesnick, 1990). Cer-1-P has been
reported to modulate cellular proliferation and the expression
of proliferating cell nuclear antigen (PCNA) in fibroblasts
(Gómez-Muñoz et al., 1995a, 1997).
The inner ear in vertebrates derives from the otic vesicle,
which goes through a period of intense cell proliferation that is
accompanied by morphogenesis. Cochleovestibular ganglion
(CVG) cells form from the ventromedial aspect of the otic
vesicle from where neuroblasts migrate and proliferate. Then,
post-mitotic neuroblasts differentiate and start to extend
processes towards their central and peripheral targets (Hemond
and Morest, 1991). Both NGF and IGF-I have been reported to
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chick embryo, IGF-I is a potent mitogen for the epithelial cells
of the otic vesicle, and it also induces cellular proliferation and
neurite outgrowth in the CVG (León et al., 1995a; Y. León and
I. Varela-Nieto, unpublished). IGF-I high affinity receptors are
expressed in the inner ear, and inmunocytochemical studies
indicate endogenous expression of this factor at embryonic day
2 and 3 (León et al., 1995a). NGF induces cell proliferation in
the CVG but not in the otic vesicle (Represa and Bernd, 1989;
Represa et al., 1991). NGF low affinity receptors, the p75
glycoprotein, are expressed in the otic vesicle and ganglion (von
Bartheld et al., 1991; Wu and Oh, 1996). 
The aim of this work is to study the role of sphingomyelin-
derived metabolites in the regulation of cell survival and its
relation with NGF and IGF-I. We report here that Cer and Cer-
1-P antagonistically modulate cell survival in the otic vesicle.
Addition of exogenous Cer or Cer-1-P to chick embryo
organotypic cultures has opposite effects in the inner ear
suggesting that the balance between these metabolites may
contribute to determine cell fate and that this balance may be
regulated by NGF and IGF-I.
MATERIALS AND METHODS
Materials
Recombinant NGF was from UBI (Lake Placid, NY). Chicken and
human recombinant IGF-I were purchased from Gropep (Adelaide,
Australia) and Boehringer Mannheim (Mannheim, Germany),
respectively. Both factors are equipotent when assayed in organotypic
cultures of chicken otic vesicles (Y. León and I. Varela-Nieto,
unpublished observation). 
Antibodies to PCNA were from Concepta Biosystems, SA
(Barcelona, Spain). Cell permeable acetyl-Cer and octanoyl-Cer-1-P
were from Matreya Inc. (Pleasant Gap, PA) and Calbiochem (San
Diego, CA), respectively. Bacterial sphingomyelinase was from
Sigma Chemical Co (St Louis, MO). [3H]thymidine (49 Ci/mmol) and
[3H]palmitic acid (52 Ci/mmol) were from Amersham Ltd (Little
Chalfont, UK). 
Preparation of organotypic cultures.
Fertilised eggs (Granja Rodríguez Serrano, Salamanca, Spain) were
incubated at 38°C in a humidified atmosphere and were staged
according to the criteria of Hamburger and Hamilton (1951). Embryos
were removed from eggs and placed in 35 mm Petri dishes (NUNC,
Roskilde, Denmark) containing PBS. Otic vesicles were dissected
from chick embryos corresponding to stage 18 (embryonic day 2.5)
using a dissection stereomicroscope and transferred into four-well
culture plates (NUNC). The standard culture medium consisted of
serum-free M199 medium with Earle’s salts (Biowhitaker,
Walkersville, MD) supplemented with 2 mM glutamine
(Biowhitaker), and antibiotics (penicillin, 50 i.u./ml and streptomycin,
50 m g/ml) (Biochrom, Berlin, Germany). Fetal bovine serum was
purchased from Biowhitaker. Incubations were carried out at 37°C in
a water-saturated atmosphere containing 5% CO2. Otic vesicles were
made quiescent by incubation in serum-free medium for 24 hours
before the different experiments were performed. 
Immunoblotting
For western blotting, otic vesicle explants were homogenised in
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer with 1 mM phenylmethylsulfonyl fluoride and
frozen immediately. Gels were loaded with solutions containing equal
amounts of protein, typically one otic vesicle per condition. Otic
vesicle proteins were resolved by using 10% SDS-PAGE and thentransferred onto PVDF membranes (Dupont-NEN, Boston, MA).
Filters were blocked with Tris-buffered saline containing 5% (w/v)
non-fat dried milk, and incubated with the primary specific antibody.
Filters were subsequently washed and incubated with the
corresponding secondary antibody conjugated with peroxidase.
Bound peroxidase activity was visualised by chemiluminescence
(Dupont-NEN) and quantified by densitometry.
Proliferative cell nuclear antigen (PCNA) is a non-histone nuclear
protein of 36 kDa that is associated with regulation of the cell cycle,
and it is essential for DNA synthesis (Bravo and MacDonald-Bravo,
1987). Mouse monoclonal anti-PCNA was used at a dilution of
1:2,000. Secondary antibodies conjugated with peroxidase were
purchased from Bio-Rad, CA.
Otic vesicle labelling and determination of
[3H]sphingomyelin hydrolysis
Otic vesicles were isolated from stage 18 chick embryos and labelled
with 25 m Ci/ml of [3H]palmitic acid for 24 hours, in the presence of
1% fetal bovine serum. Otic vesicles were washed with PBS, placed
on culture dishes in serum-free medium at 37°C for a further period
of 3 hours and stimulated with either sphingomyelinase or NGF as
indicated. Cellular lipids were extracted and labelled Cer was isolated
as indicated (Gómez-Muñoz et al., 1997). Briefly, lipids were
extracted according to the method of Bligh and Dyer (1959) except
that phases were separated by adding 2 M KCl in 0.2 M H3PO4 instead
of water. The organic phase was dried under N2 and the lipid extracts
were applied onto thin-layer plates (silica Gel G60 t.l.c., Merck,
Darmstadt, Germany) which were developed twice with
chloroform/methanol/acetic acid (9:1:1, by vol.). The material which
commigrated with cold Cer standards was scraped and extracted with
1 ml methanol at 37°C. Radioactivity associated with the spots was
determined by scintillation counting. Alternatively, labelled
sphingolipids were resolved on t.l.c. plates as described above but
dried plates were impregnated with En3Hance (Amersham) and
subjected to autoradiography.
Determination of [3H]thymidine incorporation in otic
vesicle cultures
Otic vesicle explants were cultured in medium containing
[3H]thymidine (0.2 m M, 10 m Ci/ml) for 24 hours. Incubations were
carried out at 37°C in a water-saturated atmosphere containing 5%
CO2. Otic vesicles were then individually rinsed three times with PBS.
Explants were then treated with 10% trichloroacetic acid and the
radioactivity incorporated determined by liquid scintillation counting
(OptiPhase ‘HiSafe’ liquid scintillation cocktail. Wallac, Turku,
Finland). 
Cell death determination by immunoassay and TUNEL
staining
Quantification of cell death was performed by using the Cell Death
Detection ELISA from Boehringer Mannheim, which is based on the
detection of histone-associated DNA fragments (mono-and oligo-
nucleosomes) in the cytoplasm of cells. Cultured otic vesicles were
homogenized and the cell extracts subjected to enzyme-linked
immunosorbent assay (ELISA) determination basically as indicated
by the manufacturer.
Distribution of apoptotic cells in the otic vesicle was determined by
TUNEL staining with the modifications reported (Blaschke et al.,
1996) and adapted to whole organ labelling (B. Díaz, F. de Pablo and
E. J. de la Rosa, unpublished data). Fragmented DNA was labelled
with Biotin-dUTP by the terminal transferase reaction according to
the manufacturer’s instructions (Boehringer Mannheim). Apoptotic
nuclei were visualised with Cy2-Streptavidin (Amersham) and
analysed with a MRC1024 Bio-Rad confocal microscope. 
All data are expressed as the means ± s.e.m. unless stated otherwise.
Statistical evaluation was by conformity t-test.
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RESULTS
Opposite effects of exogenous Cer and Cer-1-P in
otic vesicle cultures
In the following experiments Cer and Cer-1-P were added to
quiescent otic vesicles and tested for cell proliferation.
Treatment of quiescent organotypic otic vesicle cultures with
5 m M Cer for 24 hours induced disruption of the otic vesicle
(Fig. 1A) and no changes in PCNA expression (Fig. 1B). By
contrast, addition of 25 m M Cer-1-P caused a modest increase
in explant size of about 1.7-fold, which was concomitant with
the induction of PCNA levels (Fig. 1B). Samples treated with
1 nM IGF-I are shown for comparison. Cer blocked the
effects of Cer-1-P on PCNA expression even at a
concentration of Cer-1-P 5 times higher than those of Cer. In
contrast, 1 nM IGF-I counteracted to large extent the effects
of Cer (Fig. 1B).
Experiments on [3H]thymidine incorporation into DNA
indicated that explants treated with Cer, did not incorporate
labelling when compared with control quiescent otic vesicles
(Fig. 2A, filled symbols), whereas those treated with Cer-1-P
incorporated [3H]thymidine up to 1.8-fold over explants kept
in free-serum medium (Fig. 2A, open symbols). Both effects
were dose-dependent. Mitogenic lipids such as
lysophosphatidic acid (10-50 m M), sphingosine (5-25 m M),
sphingosine-1-phosphate (5-10 m M) or sphingosyl-
phosphorylcholine (5 m M), had no significant effect on
[3H]thymidine uptake by the otic vesicles in two different
experiments performed in quadruplicate (data not shown).
Higher doses tested were cytotoxic in this system, as reported
for other cell types (Spiegel and Merrill, 1996). Furthermore,
addition of up to 10 units/ml of phospholipase D to the cultures
did not induce cell growth (data not shown). Therefore, it
appears that Cer-1-P is specific for the stimulation of
[3H]thymidine uptake in this system. A similar approach was
used to quantify IGF-I cytoprotective activity. IGF-I was able
to suppress Cer effects which in turn partially counteracted
IGF-I-stimulation of cell growth (Fig. 2B). 
These data suggest that both lipid messenger molecules have
opposite effects in otic vesicle development. Whereas Cer data
could be explained by an increase in apoptotic cell death in the
cultures, the role of Cer-1-P was less clear. Was it protecting
otic vesicle explants from starvation-induced cell death, or was
it a low-potency proliferative agonist? To quantify the effects
on cell death resulting from the addition of Cer or Cer-1-P,
soluble nucleosomes were measured in otic vesicle extracts by
using a Cell Death Detection ELISA kit. Mono-and
oligonucleosomes are present in the cytoplasm of cells
undergoing apoptotic cell death, but not in necrotic cells
(Collins and López Rivas, 1993). As shown in Table 1, Cer was
a potent inductor of apoptosis in otic vesicle organotypic
cultures and Cer-1-P prevented cell death. Again, IGF-I was
able to suppress Cer-induced apoptosis, however, Cer-1-P did
not. These results are in contrast with those obtained in otherFig. 1. (A) Effects of Cer and Cer-1-P on explanted otic vesicles. Otic vesicles were explanted from stage 18 chick embryos and cultured for 24
hours in the absence of serum (0S), or with either 5 m M Cer, 25 m M Cer-1-P, 1 nM IGF-I or combinations of these agonists as indicated. The
photographs of the explants shown are representative of at least five different experiments performed in quadruplicate. Bar, 100 m m.
(B) Expression of proliferating cell nuclear antigen (PCNA). Otic vesicles were incubated for 24 hours in serum free medium or in the presence
of the different additives as indicated. Lysates were analysed by SDS-PAGE and western blotting as described in Materials and Methods. PCNA
spots were quantified by densitometry. Average densitrometrical values are plotted on bars. Symbols are as above. Results are expressed relative
to the control value (no serum, 0S) and they are given as means ± s.e.m. of five independent experiments performed in triplicate. The
significance of the differences between incubations under the different conditions is as follows: *P<0.05 and **P<0.001. A representative blot
of otic vesicles incubated under the different conditions is shown in the lower layer.
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*Fig. 2. (A) Effects of Cer-1-P and Cer on [3H]thymidine
uptake by otic vesicle cultures. Otic vesicles were cultured
in serum-free medium containing [3H]thymidine in the
presence of Cer-1-P (open symbols) or Cer (filled
symbols) at the concentrations that are indicated. Results
are expressed relative to the control value. The values are
given as mean ± s.e.m. of four experiments performed in
quintuplicate. (B) Effects of the addition of IGF-I on
[3H]thymidine uptake. Quiescent otic vesicles were
cultured for 24 hours with no serum, 1 nM IGF-I or with 5
m M Cer in the presence or absence of 1 nM IGF-I. Data
are expressed as mean ± s.e.m. of at least four different
experiments with an average of five explants per data
point. Statitiscal significance is as follows: *P<0.05 and
**P<0.001 vs no serum.systems. Cer has been reported to block IGF-I action by
reducing tyrosine phosphorylation of the insulin receptor
substrate-1 (Kanety et al., 1996). In the otic vesicle, however,
IGF-I is a survival factor able to block Cer-induced apoptosis
suggesting that in this system there are alternative routes of
signalling.
Characterisation of an endogenous sphingomyelin
pathway
At this point it was important to assess the physiological
relevance of the observed effects of Cer and Cer-1-P. To this
end we performed the following experiments. Otic vesicle
explants were labelled with [3H]palmitic for 24 hours. At the
end of the labelling period, different doses of
sphingomyelinase were added and the incubation continued for
a further period of 2 hours. Reaction was stopped by freezing
the samples in dry ice and lipids extracted and separated by
t.l.c. (Gómez-Muñoz et al., 1997). Finally, the amount of
[3H]Cer released was quantified. Fig. 3A shows a typical
chromatographic profile of labelled lipids which are compared
with lipid standards. The profile indicates the presence of
sphingomyelin (SM in Fig. 3A) and Cer in the inner ear. Fig.
3B shows that otic vesicle endogenous sphingomyelin is
sensitive to sphingomyelinase hydrolysis. Sphingomyelinase is
implicated in the generation of Cer that leads to DNA
fragmentation (Wiegmann et al., 1994). Cer release is dose-Fig. 3. (A) Labelling of sphingomyelin and
Cer with palmitic acid. Five otic vesicle
explants were labelled for 24 hours with
[3H]palmitic acid and treated or not with
sphingomyelinase (SMase) for three hours,
after which total cellular lipids were extracted
and both sphingomyelin and Cer were
purified by sequential t.l.c. procedures as
described in Materials and Methods. The data
are taken from a representative experiment
performed in triplicate. Total number of
different experiments performed was four.
The position of marker lipids are indicated:
CER, ceramide; SM, sphingomyelin.
(B) Dose-dependency of sphingomyelinase-
stimulated sphingomyelin hydrolysis in
isolated otic vesicles. 5 explants were labelled
as above with [3H]palmitic acid before
incubation with increasing doses of
sphingomyelinase (SMase) for three hours.
Radiolabelled Cer was isolated by t.l.c. and
the amount of radioactivity associated with
the cold Cer carrier was assessed as described
in Materials and Methods. The results are
representative of two experiments performed
in triplicate. 
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Fig. 4. NGF stimulates generation of Cer. Otic vesicles were labelled
with 25 m Ci/ml of [3H]palmitic acid for 24 hours. Then, the vesicles
were incubated in serum-free medium containing 4 nM NGF for the
periods (hours) that are indicated. Lipids were analysed as described
in Materials and Methods. Results are from a representative
experiment and they were confirmed in two independent experiments
that were performed in quintuplicate. The release of [3H]Cer after 3
hours of incubation with NGF was about 7-fold higher than control
values.
Table 1. Cell death in E 2.5 otic vesicles
No serum (n=12) 100
Cer (n=13) 145±5*
Cer-1-P (n=12) 88±5†
Cer+Cer-1-P (n= 9) 148±9*
IGF-I (n=13) 80±3†
IGF-I + Cer (n=10) 93±5‡
Otic vesicles were isolated and treated with ceramide (5 m M, Cer),
ceramide-1-phosphate (25 m M, Cer-1-P) or IGF-I (1 nM). Soluble
nucleosomes were quantified in single otic vesicle explants. For each
experiment the absorbance obtained in otic vesicles cultured in the absence of
serum was given a value of 100; n, the total number of explants tested in at
least 5 different experiments. Statistical significance is as follows: *P<0.001,
†P<0.05, vs no serum and ‡P<0.001 vs Cer.dependent and it reached saturation at a concentration of
sphingomyelinase of about 5 units/ml. 
NGF-induced generation of endogenous Cer
The next step was to test whether sphingomyelin hydrolysis
could be stimulated by physiological factors. NGF was the
preferred candidate since it has been shown to induce Cer
production (Dobrowsky et al., 1994; Casaccia-Bonnefil et al.,
1996) and cell death in the developing retina (Frade et al., 1996).
In addition, patches of expression of p75 receptor have been
reported in the vesicular epithelium (Wu and Oh, 1996). These
results are consistent with the idea that a restricted pool of cells
may be able to sense NGF and enter apoptosis. NGF (4 nM)
induced the generation of endogenous Cer (Fig. 4). Cer release
was maximal after three hours of incubation. The ability of NGF
to induce apoptosis in otic vesicle cultures was measured in
parallel and rendered a value of 165±11 (n=14, P<0.001) that
should be compared with data presented in Table 1.
To further study whether NGF modulates cell death in the
inner ear we used the TUNEL assay. This approach is indicated
to analyse DNA fragmentation in individual apoptotic cells in
a population. As shown in Fig. 5, NGF induced apoptotic cell
death in three particular areas (D-G): (i) at the ventromedial
wall of the otocyst, where the CVG is being formed (E,F); (ii)
within the CVG (D); and (iii) at the dorsal wall of the otocyst,
which corresponds with the area of development of the
endolymphatic duct (G). Exogenous Cer induced cell death but
with a less restricted pattern (H-K). Compare H with control
explant (A) cultured in no serum, and H with D. However, cell
death was more intense in the areas mentioned above,suggesting that those cell populations are somehow primed to
die. Finally, Cer-1-P suppressed starvation-induced cell death
(B and C) as compared with control quiescent otic vesicles
cultured in the absence of serum (A).
DISCUSSION
Our work shows that: (i) exogenously added Cer is a potent
activator of apoptosis in the otic vesicle; (ii) Cer-1-P is a
cytoprotector; (iii) Cer-induced cell death is suppressed by
IGF-I that is a survival factor for the developing inner ear; (iv)
NGF stimulates the sphingomyelin/Cer turnover in the otic
vesicle; and (v) NGF induces apoptosis in restricted areas of
the otic vesicle.
Apoptosis is an important physiological mechanism for
regulation of development (Jacobson et al., 1997). Signals
regulating cell death will cooperate with those managing cell
division and differentiation to control normal development and
tissue function in complex networks. Cells at certain stages
undergo apoptosis in response to a number of pharmacological
or physiological stimuli such as NGF (Dobrowsky et al., 1994;
Frade et al. 1996), whereas other growth factors prevent the
onset of apoptosis. Insulin attenuates apoptosis in the chick
embryo during neurulation (Morales et al., 1997) and IGF-I has
been shown to act as a survival factor in various cell types
including neural cells (Rodríguez-Tarduchy et al., 1992;
Matthews and Feldman, 1996; Párrizas and LeRoith, 1997).
During the early stages of inner ear development IGF-I has
been proposed to be an endogenous physiological factor
promoting cell proliferation (León et al., 1995a) and NGF has
been reported to be a proliferative signal for the attached CVG
(Represa and Bernd, 1989; Represa et al., 1991). We have
studied the signalling mechanisms mediated by lipids involved
in the regulation of apoptotic cell death and survival in
organotypic cultures of the developing ear.
Sphingomyelinases hydrolyze sphingomyelin to form
phosphocholine and Cer. Since Cer functions as a second
messenger in the induction of apoptosis, these enzymes have
been implicated in the regulation of cell death (Spiegel et al.,
1996; Hannun, 1996). We report here that Cer is a potent
inductor of apoptosis in the developing inner ear which is
consistent with previous work (Obeid et al., 1993; for a review
see Testi, 1996). On the contrary, sphingosine, sphingosine-1-
phosphate and Cer-1-P, which are metabolites of Cer, have
been reported to induce cell proliferation (Gómez-Muñoz et al.,
554 L. M. Frago and others1995a, 1997; Spiegel et al., 1996). Thus, it has been proposed
that cell fate might be determined by a dynamic equilibrium
between the production of Cer and the generation of mitogenic
lipids (Gómez-Muñoz et al., 1995b, 1997; Cuvillier et al.,
1996). Here we show that during embryonic development Cer
and Cer-1-P have opposite effects on cell survival in the
otocyst. A noteworthy difference with the cell culture systems
tested before is that sphingosine and other lipid metabolitesFig. 5. Distribution of apoptotic cells in the otocyst. Apoptotic cell death was revealed by in situ DNA-end labelling technique (TUNEL
protocol) in cultures of otocysts from embryonic day 2.5. Otic vesicles were isolated and grown for 8 hours in serum-free medium (A), 25 m M
Cer-1-P (B, C), 4 nM NGF (D, E, F, G) or 5 m M Cer (H, I, J, K). (J) Cer-treated otic vesicle at a higher magnification showing a hot spot of cell
death in the ventromedial wall. Arrowheads in J, typical rounded-shape and brighter color TUNEL-labelled cells.(B,D,H) Single projections of
the whole vesicle whereas all the other panels show 2.5 m m optic sections. Bar, 50 m m (A-I, K); 10 m m (J). cvg, cochleovestibular ganglia; vm,
ventromedial epithelium; ed, endolymphatic duct. 
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sphingosylphosphorylcholine had no detectable effects. Cer-1-
P has been reported not to be significantly metabolized to
sphingosine or sphingosine-1-phosphate in fibroblasts
(Gómez-Muñoz et al., 1995b). Natural Cer-1-P does not affect
the expression of c-fos or c-myc nor does it exhibit a clear
crosstalk with other signalling pathways relevant for cell
proliferation (Gómez-Muñoz et al., 1997). However, Cer-1-P
modulates the levels of PCNA that it is associated with
progression of cell cycle and with DNA repair (Bravo and
MacDonald-Bravo, 1987; Dietrich, 1993). Our data indicate
that Cer-1-P is not a mitogen but a cytoprotector for otic vesicle
explants acting as a suppressor of cell death upon withdrawal
of serum. Hence, at least during development, the role of
endogenous Cer-1-P might be the maintenance of cell survival
probably by a mechanism involving upregulation of PCNA. 
The p75 neurotrophin receptor is structurally related to
tumor necrosis factor receptor and Fas family (Beutler and van
Huffel, 1994). These receptors couple to at least two parallel
signalling pathways to drive either apoptotic cell death or
activation of the transcription factor NFk B (Carter et al., 1996).
The presence of a death domain motif has been shown in p75
NGF receptor (Rabizadeh and Bredesen, 1994) which upon
neurotrophin binding activates the sphingomyelin pathway to
produce Cer (Dobrowsky et al., 1994; Cassacia-Bonnefil et al.,
1996). The presence of p75 NGF receptor has been extensively
reported at different stages of inner ear development in several
animal species including chicken (von Bartheld et al., 1991;
Schecterson and Bothwell, 1994). Wu and Oh (1996) recently
proposed that the restricted pattern of expression of p75
receptors within the otocyst epithelium is associated with
presumtive sensory organ areas. Furthermore, recent work by
Fekete and colleagues (Fekete et al., 1997) has provided
evidence that cell death is a major player in morphogenesis of
the semicircular canals. Our data indicate that NGF induces
cell death in both the otic vesicle and the attached sensory
ganglia, the CVG. NGF-induced apoptosis is apparent in three
main areas which correlate well with earlier morphological
descriptions of cell death in chicken (Valdecasas et al., 1977;
Ard and Morest, 1984). A dorsal area where the endolymphatic
duct develops, a ventromedial area where migration of
placodial cells occurs pari pasu with early histogenesis of the
CVG (Li et al., 1987), and finally the CVG itself which was
the area with most abundant apoptotic nuclei. Apoptosis
observed at the ventromedial area may be implicated in the
control of the number of neuroblast precursors as suggested by
earlier work (Ard and Morest, 1984). These results suggest a
role for NGF and NGF-induced apoptosis in the early
morphogenesis and neurogenesis of inner ear. Hence, in
addition to its contribution in maintaining normal cell numbers,
programmed cell death may also contribute to the formation of
the endolymphatic duct and to the differentiation of the CVG.
We also show that IGF-I in addition to promote cell division
acts by protecting the cells of the otocyst from apoptosis. At
this stage of development there are specific areas within the
otic vesicle epithelium, the ventral and medial aspects, with
higher mitotic activity (Represa et al., 1988; Alvarez et al.,
1989; De la Pompa et al., 1995). The pattern of mitotic activity
coincides with that of c-fos expression (León et al., 1995b).
Therefore, the otic vesicle consists of an epithelium
morphologically homogeneous, but it has regional specificityand possibly cell fate specificity (reviewed by Torres and
Giraldez, 1997). 
We propose that NGF and IGF-I may regulate normal
growth of the otic vesicle via induction of regionally restricted
areas of cell death and cell proliferation. 
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